Table 4 |
||
|
Lymphoma dataset from [1] (mature aggressive B-cell lymphoma). Mapping of node numbers in Figure 4, the abbreviations used in [1], and the molecular characteristics. |
||
|
node nr |
abbrev. in Jacob et al. |
molecular characteristic |
|
|
||
|
1 |
CD10 |
Antibodies for biomarker CD10 are present in histological section of lymphoma tissue |
|
2 |
Ki-67 |
Antibodies for biomarker Ki-67 are present in histological section of lymphoma tissue |
|
3 |
CD5 |
Antibodies for biomarker CD5 are present in histological section of lymphoma tissue |
|
4 |
bcl6BR |
Breakpoint in the BCL6 locus |
|
5 |
IGH-BCL2 |
Fusion of BCL locus to immunoglobulin IGH |
|
6 |
ABC |
Gene expression profile similar to activated B-cells |
|
7 |
GCB |
Gene expression profile similar to germinal center B-cells |
|
8 |
mBL |
Gene expression signature which characterices molecular Burkitt lymphoma (Hummel et al.) |
|
9 |
non-mBL |
Absent gene expression signature non-mBL. |
|
10 |
IG-MYC |
Translocation of MYC locus involving fusion of MYC to immunoglobulins IGH, IGK or IGL |
|
11 |
atyp.myc |
Breakpoint in the MYC locus without fusion to an immunoglobulin |
|
12 |
MYC- |
No abberation of the MYC locus |
|
13 |
CD10- |
Antibodies for biomarker CD10 are absent in histological section of lymphoma tissue |
|
14 |
Ki-67- |
Antibodies for biomarker Ki-67 are absent in histological section of lymphoma tissue |
|
15 |
CD5- |
Antibodies for biomarker CD5 are absent in histological section of lymphoma tissue |
|
16 |
bcl6BR- |
No breakpoint in the BCL6 locus |
|
17 |
IGH-BCL2- |
No fusion of BCL locus to immunoglobulin IGH |
|
|
||
|
Böcker et al. BMC Bioinformatics 2009 10(Suppl 1):S61 doi:10.1186/1471-2105-10-S1-S61 |
||